{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:44:42Z","timestamp":1791431082540,"version":"4.3.3"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010221","name":"Higher Education Commision, Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ijpharm.2020.119033","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T02:06:39Z","timestamp":1579140399000},"page":"119033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"special_numbering":"C","title":["Nanostructured lipid carriers-mediated brain delivery of carbamazepine for improved in vivo anticonvulsant and anxiolytic activity"],"prefix":"10.1016","volume":"577","author":[{"given":"Namrah","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawad Ali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isra","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Mohsin","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhar ud","family":"Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Zaki Husain","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqar","family":"Aman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwan-Yeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9537-4897","authenticated-orcid":false,"given":"Alam","family":"Zeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2020.119033_b0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1014814924965","article-title":"Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2\u2013093, and BIA 2\u2013024","volume":"27","author":"Ambrosio","year":"2002","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ijpharm.2020.119033_b0010","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijpharm.2018.11.028","article-title":"Rethinking carbamazepine oral delivery using polymer-lipid hybrid nanoparticles","volume":"554","author":"Ana","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2020.119033_b0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2008.02.007","article-title":"Design and production of nanoparticles formulated from nano-emulsion templates- A review","volume":"128","author":"Anton","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2020.119033_b0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1211\/jpp.58.1.0008","article-title":"Carbamazepine uptake into rat brain following intra-olfactory transport","volume":"58","author":"Barakat","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2020.119033_b0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/157341309787314665","article-title":"Promises of nanotechnology for drug delivery to brain in neurodegenerative diseases","volume":"5","author":"Baratchi","year":"2009","journal-title":"Curr. Nanosci."},{"key":"10.1016\/j.ijpharm.2020.119033_b0030","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.addr.2007.04.011","article-title":"Solid lipid nanoparticles for targeted brain drug delivery","volume":"59","author":"Blasi","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2020.119033_b0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.31887\/DCNS.2015.17.3\/mbourin","article-title":"Animal models for screening anxiolytic-like drugs: a perspective","volume":"17","author":"Bourin","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.ijpharm.2020.119033_b0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"Bourin","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2020.119033_b0045","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1476-5381.2011.01456.x","article-title":"Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, exerts antiepileptic effects via the GABA\/benzodiazepine receptor complex in mice","volume":"164","author":"Chen","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2020.119033_b0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijpharm.2008.05.039","article-title":"Development and evaluation of novel itraconazole-loaded intravenous nanoparticles","volume":"362","author":"Chen","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2020.119033_b0055","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.2147\/IJN.S146315","article-title":"Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors","volume":"12","author":"Din","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpharm.2020.119033_b0060","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jddst.2019.02.026","article-title":"Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product","volume":"51","author":"Din","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2020.119033_b0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijpharm.2018.08.062","article-title":"Multifunctional carbamazepine loaded nanostructured lipid carrier (NLC) formulation","volume":"550","author":"Elmowafy","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2020.119033_b0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1166\/jbn.2009.1042","article-title":"Lipid nanomedicines for anticancer drug therapy","volume":"5","author":"Estella-Hermoso de Mendoza","year":"2009","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2020.119033_b0075","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.nano.2011.04.004","article-title":"Design and potential application of PEGylated gold nanoparticles with size-dependent permeation through brain microvasculature","volume":"7","author":"Etame","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpharm.2020.119033_b0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","article-title":"Approaches to transport therapeutic drugs across the blood\u2013brain barrier to treat brain diseases","volume":"37","author":"Gabathuler","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijpharm.2020.119033_b0085","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1021\/nn501292z","article-title":"Precision nanomedicine in neurodegenerative diseases","volume":"8","author":"Goldsmith","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpharm.2020.119033_b0090","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.2147\/IJN.S109088","article-title":"Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression","volume":"11","author":"He","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2020.119033_b0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.colsurfb.2005.08.005","article-title":"Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system","volume":"45","author":"Hu","year":"2005","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2020.119033_b0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.colsurfb.2016.03.040","article-title":"Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization","volume":"143","author":"Islan","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2020.119033_b0105","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1476-5381.2011.01604.x","article-title":"2\u2032-Methoxy-6-methylflavone: a novel anxiolytic and sedative with subtype selective activating and modulating actions at GABAA receptors","volume":"165","author":"Karim","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2020.119033_b0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2007.12.018","article-title":"Potential of solid lipid nanoparticles in brain targeting","volume":"127","author":"Kaur","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2020.119033_b0115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3389\/fphar.2016.00499","article-title":"Anticonvulsant, anxiolytic, and sedative activities of Verbena officinalis","volume":"7","author":"Khan","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijpharm.2020.119033_b0120","doi-asserted-by":"crossref","first-page":"48101","DOI":"10.1039\/C4RA08495K","article-title":"Ultrafine carbamazepine nanoparticles with enhanced water solubility and rate of dissolution","volume":"4","author":"Kumar","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijpharm.2020.119033_b0125","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.0013-9580.2005.31904.x","article-title":"Potential role of drug transporters in the pathogenesis of medically intractable epilepsy","volume":"46","author":"Kwan","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.ijpharm.2020.119033_b0130","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.addr.2011.10.003","article-title":"Host factors affecting antiepileptic drug delivery\u2014Pharmacokinetic variability","volume":"64","author":"Landmark","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2020.119033_b0135","doi-asserted-by":"crossref","first-page":"e93158","DOI":"10.1371\/journal.pone.0093158","article-title":"The anticonvulsant effects of SR 57227 on pentylenetetrazole-induced seizure in mice","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2020.119033_b0140","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2147\/IJN.S57565","article-title":"Formulation and delivery of itraconazole to the brain using a nanolipid carrier system","volume":"9","author":"Lim","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2020.119033_b0145","first-page":"72","article-title":"Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain","volume":"13","author":"Liu","year":"2018","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2020.119033_b0150","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/10611860400015936","article-title":"Nanoparticle surface charges alter blood-brain barrier integrity and permeability","volume":"12","author":"Lockman","year":"2004","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2020.119033_b0155","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpharm.2009.01.014","article-title":"Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery","volume":"372","author":"Lv","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2020.119033_b0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/1028415X.2017.1357919","article-title":"Anticonvulsant effects of thiamine on pentylenetetrazole-induced seizure in mice","volume":"22","author":"Mesdaghinia","year":"2019","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.ijpharm.2020.119033_b0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00180-1","article-title":"Nanostructured lipid matrices for improved microencapsulation of drugs","volume":"242","author":"M\u00fcller","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2020.119033_b0170","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/02652048.2017.1337247","article-title":"Sustained release docetaxel-incorporated lipid nanoparticles with improved pharmacokinetics for oral and parenteral administration","volume":"34","author":"Qureshi","year":"2017","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpharm.2020.119033_b0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejpb.2016.09.008","article-title":"Enhanced acute anti-inflammatory effects of CORM-2-loaded nanoparticles via sustained carbon monoxide delivery","volume":"108","author":"Qureshi","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2020.119033_b0180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2019.02.002","article-title":"Simvastatin-loaded solid lipid nanoparticles for enhanced anti-hyperlipidemic activity in hyperlipidemia animal model","volume":"560","author":"Rizvi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2020.119033_b0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2020.119033_b0190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.colsurfb.2018.03.052","article-title":"Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro\/in vivo evaluation","volume":"167","author":"Scioli Montoto","year":"2018","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2020.119033_b0195","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/jps.10186","article-title":"Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method","volume":"91","author":"Sethia","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2020.119033_b0200","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s40005-016-0255-y","article-title":"Nanomedicines for oral administration based on diverse nanoplatform","volume":"46","author":"Sim","year":"2016","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ijpharm.2020.119033_b0205","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1017\/S1092852900008464","article-title":"The consequences of uncontrolled epilepsy","volume":"9","author":"Sperling","year":"2004","journal-title":"CNS Spectr."},{"key":"10.1016\/j.ijpharm.2020.119033_b0210","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","article-title":"Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases","volume":"264","author":"Tapeinos","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2020.119033_b0215","first-page":"289","article-title":"Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives","volume":"2","author":"\u00dcner","year":"2007","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpharm.2020.119033_b0220","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0922-4106(91)90111-T","article-title":"Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses","volume":"206","author":"Van Calker","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2020.119033_b0225","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nprot.2007.44","article-title":"The use of the elevated plus maze as an assay of anxiety-related behavior in rodents","volume":"2","author":"Walf","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijpharm.2020.119033_b0230","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3109\/10717544.2011.596583","article-title":"Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration","volume":"18","author":"Wen","year":"2011","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2020.119033_b0235","unstructured":"WHO, 2019. Epilepsy fact sheet. Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/epilepsy. [Accessed 28-06-2019]."},{"key":"10.1016\/j.ijpharm.2020.119033_b0240","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrneurol.2012.181","article-title":"Pharmacoresistance and the role of surgery in difficult to treat epilepsy","volume":"8","author":"Wiebe","year":"2012","journal-title":"Nature Rev. Neurol."},{"key":"10.1016\/j.ijpharm.2020.119033_b0245","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.addr.2009.11.020","article-title":"Nanotechnology applications for improved delivery of antiretroviral drugs to the brain","volume":"62","author":"Wong","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2020.119033_b0250","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40005-018-00418-8","article-title":"Potential of nanoparticulate carriers for improved drug delivery via skin","volume":"49","author":"Zeb","year":"2019","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ijpharm.2020.119033_b0255","article-title":"Neuroprotective effects of carnosine-loaded elastic liposomes in cerebral ischemia rat model","author":"Zeb","year":"2019","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.ijpharm.2020.119033_b0260","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.2147\/IJN.S109565","article-title":"Improved skin permeation of methotrexate via nanosized ultradeformable liposomes","volume":"11","author":"Zeb","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2020.119033_b0265","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/jphp.12727","article-title":"High payload itraconazole-incorporated lipid nanoparticles with modulated release property for oral and parenteral administration","volume":"69","author":"Zeb","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2020.119033_b0270","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/jps.21549","article-title":"Experimental design for the optimization of lipid nanoparticles","volume":"98","author":"Zhang","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2020.119033_b0275","series-title":"Polar Lipids","first-page":"215","article-title":"8 - Sugar fatty acid esters","author":"Zheng","year":"2015"},{"key":"10.1016\/j.ijpharm.2020.119033_b0280","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2018.05.023","article-title":"Nanoparticle-based delivery of carbamazepine: A promising approach for the treatment of refractory epilepsy","volume":"547","author":"Zybina","year":"2018","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517320300156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517320300156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:45:10Z","timestamp":1759916710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517320300156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":56,"alternative-id":["S0378517320300156"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119033","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanostructured lipid carriers-mediated brain delivery of carbamazepine for improved in vivo anticonvulsant and anxiolytic activity","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119033"}}